How Can We Help?
You are here:
< Back

Virstatin is a small molecule that inhibits the activity of the cholera protein, ToxT.[1]

Its activity in cholera was first published in 2005 in a paper that described the screening of a chemical library in a phenotypic screen and subsequent testing of one of the hits in infected mice.[1][2]

The compound is an isoquinoline alkaloid[3] and can be synthesized by a simple two-step synthesis[4]

Reaction scheme used in original discovery and analysis of the molecule

References

  1. ^ a b Anthouard R, DiRita VJ (February 2015). "Chemical biology applied to the study of bacterial pathogens". Infection and Immunity. 83 (2): 456–69. doi:10.1128/IAI.02021-14. PMC 4294262. PMID 25404026.
  2. ^ Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ (October 2005). "Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization". Science. 310 (5748): 670–4. Bibcode:2005Sci...310..670H. doi:10.1126/science.1116739. PMID 16223984. S2CID 30557147.
  3. ^ Cushnie TP, Cushnie B, Lamb AJ (November 2014). "Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities". International Journal of Antimicrobial Agents. 44 (5): 377–86. doi:10.1016/j.ijantimicag.2014.06.001. PMID 25130096. S2CID 205171789.
  4. ^ McDonald CE (2009). "A Two-Step Synthesis of Virstatin, A Virulence Inhibitor of Vibrio cholerae". J. Chem. Educ. 86 (4): 482. Bibcode:2009JChEd..86..482M. doi:10.1021/ed086p482.
Categories
Table of Contents